Genomed (WAR:GEN) Other Current Payables: zł0.00 Mil (As of Mar. 2026)


WAR:GEN Genomed SA WAR:GEN
75 GF Score
Price zł29.20
GF Value zł37.99
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Genomed Other Current Payables?

Genomed WAR:GEN -1.35% 75 Other Current Payables is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:GEN with a GF Score™ of 75/100 and a GF Value™ of zł37.99 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Genomed's Other Current Payables for the quarter that ended in Mar. 2026 was zł0.00 Mil.

Genomed's annual Other Current Payables increased from Dec. 2023 (zł0.00 Mil) to Dec. 2024 (zł0.00 Mil) but then declined from Dec. 2024 (zł0.00 Mil) to Dec. 2025 (zł0.00 Mil).

Genomed Other Current Payables Related Terms

Genomed Other Current Payables Historical Data

* Premium members only.

The historical data trend for Genomed's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomed Other Current Payables Chart

Genomed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Genomed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:GEN
75GF Score
Genomed SA WAR:GEN
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomed Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of zł0.00 Mil mean?
Genomed (WAR:GEN) has a Other Current Payables of zł0.00 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genomed and its competitors.
Is Genomed's Other Current Payables too high?
Genomed's current Other Current Payables is zł0.00 Mil. Overall, Genomed has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomed's Other Current Payables compare to TMO and DHR?
Genomed's Other Current Payables of zł0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genomed and its competitors. Genomed's current Other Current Payables is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomed stock overvalued right now?
Based on GuruFocus' analysis, Genomed (WAR:GEN) is currently considered Modestly Undervalued. The stock's GF Value™ is zł37.99, compared to a current price of zł29.20 — trading 23.1% below its estimated fair value. The current Other Current Payables is zł0.00 Mil. Genomed's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Genomed (WAR:GEN), the current Other Current Payables is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomed (WAR:GEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genomed stock appears to be undervalued. The current stock price of zł29.20 is trading 23.1% below its estimated GF Value™ of zł37.99. GuruFocus considers Genomed to be Modestly Undervalued.

Key valuation signals for WAR:GEN:

  • Other Current Payables: zł0.00 Mil
  • GF Value™: zł37.99 vs. price of zł29.20 (23.1% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the WAR:GEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomed Business Description

Address Ulica Ponczowa 12, Warszawa, POL, 02-971
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
75GF Score

Get the complete analysis for WAR:GEN

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł29.20
Price
zł37.99
GF Value